Telangana targets Rs.1 lakh crore investments in Life Sciences by 2030
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell
Report highlights significant improvements in adolescent well-being in India
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Subscribe To Our Newsletter & Stay Updated